Financhill
Back

Adagene 10K Form

Sell
30

ADAG
Adagene

Last Price:
2.83
Seasonality Move:
39.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADAG News And Ratings

See the #1 stock for the next 7 days that we like better than ADAG

ADAG Financial Statistics

Sales & Book Value

Annual Sales: $18.11M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.28
Price / Book: 2.46

Profitability

EPS (TTM): -0.72500
Net Income (TTM): $-31.85M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Adagene Earnings Forecast

Key Adagene Financial Ratios

  • The Research & Development expenses have been 202.30% of Revenue.
  • The Interest Expense is -5.85% of Operating Income.
  • The Net Earning history of ADAG is -104.61% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Adagene Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADAG
Website: adagene.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADAG Technical Analysis vs Fundamental Analysis

Sell
30
Adagene (ADAG) is a Sell

Is Adagene a Buy or a Sell?

  • Adagene stock is rated a Sell
    The current Adagene [ADAG] share price is $3.15. The Score for ADAG is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.